Skip to main content

Find Clinical Trials

Home
Conditions
Refractory Acute Myeloid Leukemia

Clinical trial condition

Refractory Acute Myeloid Leukemia

Explore clinical trials studying Refractory Acute Myeloid Leukemia. Study availability and eligibility vary by location and protocol.

100 public trials 42 recruiting studies

Refine in advanced search Browse all conditions

Refractory Acute Myeloid Leukemia trial results

Completed

Talazoparib and Gemtuzumab Ozogamicin for the Treatment of CD33 Positive Relapsed or Refractory Acute Myeloid Leukemia

NCT04207190

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +6 more
Locations: University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States

Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Phase I/II Study of Enhanced CD33 CAR T Cells in Subjects With Relapsed or Refractory Acute Myeloid Leukemia

NCT04835519

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations: Beijing Boren Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

8-Chloroadenosine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT02509546

Conditions: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

Pinometostat and Azacitidine in Treating Patients With Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia With 11q23 Rearrangement

NCT03701295

Conditions: Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLL, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Prexasertib (LY2606368), Cytarabine, and Fludarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

NCT02649764

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +16 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

OX40, Venetoclax, Avelumab, Glasdegib, Gemtuzumab Ozogamicin, and Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia

NCT03390296

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +6 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Low Dose Daunorubicin in Pediatric Relapsed/Refractory Acute Leukemia

NCT04562792

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations: Children's Mercy Hospital Kansas City, Missouri, United States

View Trial Details

Completed

Salsalate, Venetoclax, and Decitabine or Azacitidine for the Treatment of Acute Myeloid Leukemia or Advanced Myelodysplasia/Myeloproliferative Disease

NCT04146038

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +21 more
Locations: Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States

View Trial Details

Completed

Efficacy and Safety of HVA Regimens as Salvage Treatment in rrAML

NCT04424147

Conditions: Bone Marrow Diseases, HVA Regimen, Hematologic Diseases, +11 more
Locations: Department of Hematology,Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Completed

Sequential Conditioning in Haploidentical Transplantation for Refractory Acute Myeloid Leukemia

NCT03035422

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations: Service d'hématologie Clinique Hôpital Saint Antoine Paris, France

View Trial Details